MarketCap
Facebook
X
TelegramAdamas Pharmaceuticals, Inc. Total Current Liabilities 2011-2026 | ADMS
Annual Total Current Liabilities Adamas Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 34.9 M | 26.9 M | 24.3 M | 16.6 M | 9.74 M | 11.8 M | 12.5 M | 4.22 M | 38.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.5 M | 4.22 M | 19.9 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CRISPR Therapeutics AG
CRSP
|
149 M | $ 48.78 | 0.95 % | $ 4.12 B |  Schweiz |
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M |  USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
38.2 M | $ 2.82 | -9.03 % | $ 159 M | China |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 0.83 | 1.13 % | $ 4.53 M | China |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
4.46 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Athira Pharma
ATHA
|
13.1 M | - | - | $ 269 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
54.1 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
5.04 M | $ 3.93 | 1.16 % | $ 335 M | USA |
 |
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
66.3 M | - | -6.81 % | $ 3.04 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
36.9 M | - | 17.91 % | $ 11.1 M | USA |
 |
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M | USA |
 |
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | USA |
 |
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | USA |
 |
BeiGene, Ltd.
BGNE
|
2.21 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.38 | -3.85 % | $ 352 M |  Britain |
 |
Amneal Pharmaceuticals
AMRX
|
1.13 B | $ 14.65 | -0.37 % | $ 4.53 B | USA |
 |
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
63.1 M | $ 2.2 | -3.08 % | $ 13.8 M | USA |
 |
Bristol-Myers Squibb Company
BMY
|
23.4 B | $ 59.99 | 0.1 % | $ 122 B | USA |